Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Selvan Ravindran, Santosh Kapil Kumar Gorti, Sudipta Basu, Prashant Surve and Pradnya Honrao
Studies were conducted on the Metabolism of sulfonylurea drug glyburide (5-chloro-N-(4-[N-(cyclohexylcarbamoyl) sulfamoyl] phenethyl)-2-methoxybenzamide) in human, mouse, rat, dog and monkey hepatic microsomes. Liquid chromatography with Diode array detector (LC-DAD) hyphenated with Q-Trap-Mass Spectrometer (Q-TRAP-MS/ MS) was employed to study the metabolism of glyburide in different species. The primary objective of the present study is to identify the similarities and differences in the metabolism of glyburide and to confirm the recent newly identified metabolites across the species. Results obtained from LC-UV and LC-MS/MS confirm the similarities and differences in the biotransformation of glyburide across the species. LC-UV-MS/MS data clearly suggests that the quantities of metabolites formed in all the species are dissimilar. Drug metabolite ratio is also different in all the species considered for tests. Mono-oxygenated metabolites and a metabolite due to the ring loss were identified in all the species. Similarities and differences in the metabolism of glyburide confirm the role of cytochrome P450 (CYP 45) enzymes and its distinct activity across the species.